Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats. 1987

G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard

A novel iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, and desferrioxamine were compared for their ability to remove iron and for their site of action in iron release in rats. Repeated intraperitoneal injections of the chelators in rats with widespread tissue labelling by 59Fe derived from transferrin showed comparable 59Fe mobilisation by each chelator in normal and iron loaded rats. Specific labelling of a chelatable "cold" iron pool in hepatocytes by 59Fe derived from ferritin showed this pool to be equally accessible to parenteral doses of both chelators and also to oral 1,2-dimethyl-3-hydroxypyrid-4-one, which is an effective oral iron chelating agent that removes iron from parenchymal cells. This and other alpha-ketohydroxypyridines need further development as potential therapeutic agents in human iron overload.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D007504 Iron Radioisotopes Unstable isotopes of iron that decay or disintegrate emitting radiation. Fe atoms with atomic weights 52, 53, 55, and 59-61 are radioactive iron isotopes. Radioisotopes, Iron
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005260 Female Females
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic

Related Publications

G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
January 1993, Bone marrow transplantation,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
January 1990, Annals of the New York Academy of Sciences,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
July 1994, Journal of clinical pathology,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
April 1990, Seminars in hematology,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
April 1994, Blood,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
April 1994, Arzneimittel-Forschung,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
December 1990, British journal of haematology,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
November 1991, Nederlands tijdschrift voor geneeskunde,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
October 1990, British journal of haematology,
G J Kontoghiorghes, and L Sheppard, and A V Hoffbrand, and J Charalambous, and J Tikerpae, and M J Pippard
May 1994, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!